Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
T-Rex
Activation of Regenerative Pathways by Exercise Training in Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
80
1 country
2
Brief Summary
The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions. Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program. (ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life. (iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine. (iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started Sep 2022
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 19, 2025
August 1, 2025
3.3 years
March 7, 2024
August 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary Function
FEV1 (Forced Expiratory volume in one second)
Baseline, post intervention at 12 wks
Secondary Outcomes (5)
Physical capacity
Baseline, post intervention at 12 wks
Inflammation markers
Baseline, post intervention at 12 wks
Level of emphysema
Baseline, post intervention at 12 wks
Maximal physical capacity ( Wmax)
Baseline, post intervention at 12 wks
COPD Assessment Test (CAT)
Baseline, post intervention at 12 wks
Study Arms (1)
Exercise
EXPERIMENTALThe exercise training protocol to be used in this study: Supervised exercise training (aerobic- and muscle strengthening exercise): 2 times a week for 12 weeks. * Aerobic exercise with ergometer cycling for 30 min, at moderate intensity (60% Wpeak) individually adjusted to level 4-6 on the Borg category ratio-10 scale. * Muscle strengthening exercise will consist of 8-12 strength exercises of the major upper and lower body muscle groups. Each exercise includes three sets with 8-12 repetitions. Exercise training at home: once a week for 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator
- Optimal medical treatment according to GOLD and the Swedish National Guidelines
- Absence of other significant diseases that could contribute to physical exercise limitation
- Non-smoking since at least one year
- Free from exacerbations (last 4 weeks)
- BMI = 18- 35
You may not qualify if:
- Regular participation in adjusted/specially designed exercise sessions
- Unstable cardiovascular or pulmonary disease
- Smoking
- Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Lund Universitycollaborator
Study Sites (2)
Lund University
Lund, Sweden
Uppsala University
Uppsala, Sweden
Related Publications (1)
Larsson C, Elowsson L, Tufvesson E, Cederberg A, Ohrneman H, Falcones B, Karlsson L, Akbarshahi H, Ankerst J, Bjermer L, Palm A, Londahl J, Malinovschi A, Janson C, Emtner M, Westergen-Thorsson G. Activation of regenerative pathways by exercise intervention in subjects with chronic obstructive pulmonary disease - a study protocol. Respir Res. 2025 Dec 12. doi: 10.1186/s12931-025-03443-y. Online ahead of print.
PMID: 41388411DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 28, 2024
Study Start
September 1, 2022
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share